Methacrylic Acid

Methacrylic Acid

SCHEMBL1123736

C=C(C)C(=O)O.C=C(C)C(=O)O.CCOOc1ccc(C(C)(C)c2ccc(O)cc2)cc1

nearest known ligand 0.43

Full drug profile on Sugi Atlas →

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
ESR1 P03372 4/20 0.43
ESR2 Q92731 4/20 0.43
CYP3A4 P08684 3/20 0.43
AR P10275 1/20 0.43
HPGD P15428 1/20 0.43
TSHR P16473 1/20 0.43
SLC6A2 P23975 1/20 0.43
SLC6A4 P31645 1/20 0.43
HTR6 P50406 1/20 0.43
ESRRG P62508 1/20 0.43
SLC6A3 Q01959 1/20 0.43
HSD17B10 Q99714 1/20 0.43
ALDH1A1 P00352 8/20 0.42
KDM4E B2RXH2 8/20 0.39
POLB P06746 2/20 0.39
MEN1 O00255 3/20 0.38
KMT2A Q03164 3/20 0.38
HTT P42858 2/20 0.38
SMN1; SMN2 Q16637 3/20 0.37
GAA P10253 2/20 0.37

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL1123840 0.87 ESR1 (0.57) ESR1ESR2CYP3A4ARHPGD
Bisphenol A SCHEMBL30620172 0.82 ESR1 (0.55) ESR1ESR2CYP3A4ARHPGD
Bisphenol A SCHEMBL9147592 0.82 ESR1 (0.64) ESR1ESR2CYP3A4ARHPGD
SCHEMBL1123797 0.82 ELANE (0.44) ARALDH1A1KDM4EPOLBMEN1
Bisphenol A SCHEMBL22319407 0.82 ESR1 (0.64) ESR1ESR2CYP3A4ARHPGD
Bisphenol A SCHEMBL347900 0.82 ESR1 (0.64) ESR1ESR2CYP3A4ARHPGD
Bisphenol A SCHEMBL4219076 0.82 ESR1 (0.64) ESR1ESR2CYP3A4ARHPGD
SCHEMBL8644765 0.79 SMN1; SMN2 (0.44) ESR1ESR2CYP3A4ARHPGD
Methacrylic Acid SCHEMBL29629401 0.78 MAPT (0.40) HPGDTSHRALDH1A1KDM4ESMN1; SMN2
Methacrylic Acid SCHEMBL8843428 0.78 ALDH1A1 (0.71) ESR1ESR2CYP3A4ARHPGD

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-2284205-B1 METHOD FOR PRODUCING AN OPTICAL COMPONENT SOKEN KAGAKU KK (JP) 2016-11-02 EP disclosed
US-20140159261-A1 METHOD OF PRODUCING OPTICAL COMPONENT SOKEN CHEMICAL & ENGINEERING CO., LTD. (JP) 2014-06-12 US disclosed
US-20110077318-A1 RESIN COMPOSITION FOR PRODUCING OPTICAL COMPONENT AND USE THEREOF OMRON CORPORATION (JP) 2011-03-31 US disclosed
EP-2284205-A1 RESIN COMPOSITION FOR MANUFACTURING OPTICAL COMPONENT AND APPLICATION THEREOF Omron Corporation (JP) 2011-02-16 EP disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20110077318-A1 RESIN COMPOSITION FOR PRODUCING OPTICAL COMPONENT AND USE THEREOF CAD, RER1, ALG3 ESR1 2655/4885ESR2 3567/4885CYP3A4 3758/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.